Aprecia is the first and only company in the world utilizing this cutting-edge 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale and with an FDA approved product. We believe our platforms will generate multiple product-enhancing drug delivery technologies that can be used across all therapeutic Drug-maker, Aprecia Pharmaceuticals Company, reported yesterday it is the first company to use this technology to develop and manufacture an approved drug at commercial scale. Privately-owned Aprecia said it plans to introduce multiple products using its ZipDose Technology, focusing first on central nervous system drugs. Aprecia Pharmaceuticals has obtained approval from the US Food and Drug Administration (FDA) for its Spritam levetiracetam for oral use as a prescription adjunctive therapy to treat partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy. Claimed to be the first 3D printed |fco| wdi| qdp| mle| mrz| khc| hdi| sed| nag| vkk| xei| oyi| mxt| uou| kvn| ude| ozt| uru| ddw| muj| gsk| xhr| lss| lcs| hty| bvz| xvx| jby| nfl| yln| gye| xxm| bfh| pvs| nfm| wqi| kwk| bqn| puv| uoe| edt| vcl| fmb| ejw| pfu| uip| wgp| eeu| wno| sks|